A rare type of T immune cell can help predict which patients may benefit most from cancer immunotherapies, a new study has found.The study was published in Nature Cancer and led by researchers from King’s College London, Guy’s and St Thomas’ Hospital Trust, and the Francis Crick Institute.“Checkpoint inhibition (CPI), particularly that targeting the inhibitory […]
